# A novel genetic model provides a unique perspective on the relationship between postexercise glycogen concentration and increases in the abundance of key metabolic proteins after acute exercise

**Authors:** Seong Eun Kwak, Amy Zheng, Edward B. Arias, Haiyan Wang, Xiufang Pan, Yongping Yue, Dongsheng Duan, Gregory D. Cartee

PMC · DOI: 10.1371/journal.pone.0295964 · PLOS ONE · 2024-01-30

## TL;DR

This study uses a new genetic model to show that changes in muscle glycogen after exercise do not always match changes in key metabolic proteins.

## Contribution

A novel genetic approach was developed to modify glycogen synthase 1 in skeletal muscle for studying exercise effects.

## Key findings

- Exercise increased phosphorylated AMPK but did not affect metabolic protein abundance immediately after exercise.
- Reduced glycogen synthase 1 led to lower glycogen in refed rats but not in non-refed rats.
- PDK4 and PGC1α levels increased in GS1-knockdown muscles at 9 hours post-exercise, independent of glycogen levels.

## Abstract

Some acute exercise effects are influenced by postexercise (PEX) diet, and these diet-effects are attributed to differential glycogen resynthesis. However, this idea is challenging to test rigorously. Therefore, we devised a novel genetic model to modify muscle glycogen synthase 1 (GS1) expression in rat skeletal muscle with an adeno-associated virus (AAV) short hairpin RNA knockdown vector targeting GS1 (shRNA-GS1). Contralateral muscles were injected with scrambled shRNA (shRNA-Scr). Muscles from exercised (2-hour-swim) and time-matched sedentary (Sed) rats were collected immediately postexercise (IPEX), 5-hours-PEX (5hPEX), or 9-hours-PEX (9hPEX). Rats in 5hPEX and 9hPEX experiments were refed (RF) or not-refed (NRF) chow. Muscles were analyzed for glycogen, abundance of metabolic proteins (pyruvate dehydrogenase kinase 4, PDK4; peroxisome proliferator-activated receptor γ coactivator-1α, PGC1α; hexokinase II, HKII; glucose transporter 4, GLUT4), AMP-activated protein kinase phosphorylation (pAMPK), and glycogen metabolism-related enzymes (glycogen phosphorylase, PYGM; glycogen debranching enzyme, AGL; glycogen branching enzyme, GBE1). shRNA-GS1 versus paired shRNA-Scr muscles had markedly lower GS1 abundance. IPEX versus Sed rats had lower glycogen and greater pAMPK, and neither of these IPEX-values differed for shRNA-GS1 versus paired shRNA-Scr muscles. IPEX versus Sed groups did not differ for abundance of metabolic proteins, regardless of GS1 knockdown. Glycogen in RF-rats was lower for shRNA-GS1 versus paired shRNA-Scr muscles at both 5hPEX and 9hPEX. HKII protein abundance was greater for 5hPEX versus Sed groups, regardless of GS1 knockdown or diet, and despite differing glycogen levels. At 9hPEX, shRNA-GS1 versus paired shRNA-Scr muscles had greater PDK4 and PGC1α abundance within each diet group. However, the magnitude of PDK4 or PGC1α changes was similar in each diet group regardless of GS1 knockdown although glycogen differed between paired muscles only in RF-rats. In summary, we established a novel genetic approach to investigate the relationship between muscle glycogen and other exercise effects. Our results suggest that exercise-effects on abundance of several metabolic proteins did not uniformly correspond to differences in postexercise glycogen.

## Linked entities

- **Genes:** MYO5A (myosin VA) [NCBI Gene 4644], PDK4 (pyruvate dehydrogenase kinase 4) [NCBI Gene 5166], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], HK2 (hexokinase 2) [NCBI Gene 3099], SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517], PYGM (glycogen phosphorylase, muscle associated) [NCBI Gene 5837], AGL (amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase) [NCBI Gene 178], GBE1 (1,4-alpha-glucan branching enzyme 1) [NCBI Gene 2632]
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 5563] {aka AMPK, AMPK2, AMPKa2, PRKAA}, PYGM (glycogen phosphorylase, muscle associated) [NCBI Gene 5837] {aka GSD5}, Acaca (acetyl-CoA carboxylase alpha) [NCBI Gene 60581] {aka ACC1, Acac}, Tbc1d1 (TBC1 domain family member 1) [NCBI Gene 360937], GYS1 (glycogen synthase 1) [NCBI Gene 2997] {aka GSY, GYS}, AGL (amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase) [NCBI Gene 178] {aka GDE}, Prkaa2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 78975] {aka Ampk, Ampka2}, PUDP (pseudouridine 5'-phosphatase) [NCBI Gene 8226] {aka DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A}, SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517] {aka GLUT4}, Slc2a4 (solute carrier family 2 member 4) [NCBI Gene 25139] {aka Glut4}, PACC1 (proton activated chloride channel 1) [NCBI Gene 55248] {aka ASOR, C1orf75, PAC, PAORAC, TMEM206, hPAC}, Ppargc1a (PPARG coactivator 1 alpha) [NCBI Gene 83516] {aka LRPGC1, PGC-1v, PGCvf, PGCvf-1, PGCvf1, Ppargc1}, Pygm (glycogen phosphorylase, muscle associated) [NCBI Gene 24701] {aka Muscpho}, Pdk4 (pyruvate dehydrogenase kinase 4) [NCBI Gene 89813], Pygl (glycogen phosphorylase L) [NCBI Gene 64035], Hk2 (hexokinase 2) [NCBI Gene 25059], Gys1 (glycogen synthase 1) [NCBI Gene 690987], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, Gbe1 (1,4-alpha-glucan branching enzyme 1) [NCBI Gene 288333], GBE1 (1,4-alpha-glucan branching enzyme 1) [NCBI Gene 2632] {aka APBD, GBE, GSD4}, TBC1D1 (TBC1 domain family member 1) [NCBI Gene 23216] {aka TBC, TBC1}, HK2 (hexokinase 2) [NCBI Gene 3099] {aka HKII, HXK2}, Agl (amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase) [NCBI Gene 362029], PDK4 (pyruvate dehydrogenase kinase 4) [NCBI Gene 5166]
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Adeno-associated virus (species) [taxon 272636]
- **Cell lines:** -CMV — Homo sapiens (Human), Finite cell line (CVCL_A9D7), 5hPEX — Mus musculus (Mouse), Transformed cell line (CVCL_5U93), 9hPEX — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_RG56), L6 — Mus musculus (Mouse), Hybridoma (CVCL_XK50)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10826964/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10826964/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC10826964/full.md

---
Source: https://tomesphere.com/paper/PMC10826964